MSH6 and female reproductive organ cancer: However, the number of gynecological cancers in females carrying an MSH6 mutation were lower than expected, probably because most of our patients were identified by clinical criteria (Amsterdam and Bethesda), which are focused mainly on CRC, which is less frequent than EC in MSH6 carriers [2].